Studio Comparativo "Pronti a Salpare 2": Efficacia della Velaterapia Versus Teleriabilitazione in Pazienti con Malattie Rare Scheletriche - Valutazione degli Outcome Motori, Psicosociali e Qualità della Vita

Title

Code

PaS2-EXTEND

Type

Sperimentale

Start Year

2025

Status

In Corso

Principal Investigator

051-6366519, 051-6366681

luca.sangiorgi@ior.it

Sangiorgi Luca, MD

Director

Rare skeletal disorders

Operational unit that carry out the study

complex unit

Malattie rare scheletriche

Director

Sangiorgi Luca, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. PaS2-EXTEND

Tuesday 15 July 2025, 15:10

PG0010382_2025_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Studio Comparativo "Pronti a Salpare 2": Efficacia della Velaterapia Versus Teleriabilitazione in Pazienti con Malattie Rare Scheletriche - Valutazione degli Outcome Motori, Psicosociali e Qualità della Vita

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in